Deborah Lycett1, Linda Nichols2, Ronan Ryan2, Amanda Farley2, Andrea Roalfe2, Mohammed A Mohammed3, Lisa Szatkowski4, Tim Coleman5, Richard Morris6, Andrew Farmer7, Paul Aveyard7. 1. Coventry University, Faculty of Health and Life Sciences, Coventry, UK. Electronic address: deborah.lycett@coventry.ac.uk. 2. School of Health and Population Sciences, University of Birmingham, Birmingham, UK. 3. University of Bradford, Bradford, UK. 4. School of Medicine, University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK. 5. School of Medicine, University of Nottingham, Division of Primary Care, Medical School, Queen's Medical Centre, Nottingham, UK. 6. School of Social and Community Medicine, University of Bristol, Canynge Hall, Bristol, UK. 7. University of Oxford, Nuffield Department of Primary Care Health Sciences, New Radcliffe House Radcliffe Observatory Quarter, Oxford, UK.
Abstract
BACKGROUND: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3-5 years after smoking cessation than in continuing smokers. After 10-12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. METHODS: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. FINDINGS: 10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17-0·25; p<0·001; [2·34 mmol/mol (95% CI 1·91-2·77)]) within the first year after quitting. HbA1c decreased as abstinence continued and became comparable to that of continual smokers after 3 years. This increase in HbA1c was not mediated by weight change. INTERPRETATION: In type 2 diabetes, smoking cessation is associated with deterioration in glycaemic control that lasts for 3 years and is unrelated to weight gain. At a population level, this temporary rise could increase microvascular complications. FUNDING: National Institute for Health Research School for Primary Care Research.
BACKGROUND: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3-5 years after smoking cessation than in continuing smokers. After 10-12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. METHODS: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. FINDINGS: 10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17-0·25; p<0·001; [2·34 mmol/mol (95% CI 1·91-2·77)]) within the first year after quitting. HbA1c decreased as abstinence continued and became comparable to that of continual smokers after 3 years. This increase in HbA1c was not mediated by weight change. INTERPRETATION: In type 2 diabetes, smoking cessation is associated with deterioration in glycaemic control that lasts for 3 years and is unrelated to weight gain. At a population level, this temporary rise could increase microvascular complications. FUNDING: National Institute for Health Research School for Primary Care Research.
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Mercedes R Carnethon; Alain G Bertoni; Christina M Shay; Haitham M Ahmed; Roger S Blumenthal; Mary Cushman; Sherita H Golden Journal: Diabetologia Date: 2016-06-08 Impact factor: 10.122
Authors: Gang Liu; Yang Hu; Geng Zong; An Pan; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm; Frank B Hu; Qi Sun Journal: Lancet Diabetes Endocrinol Date: 2020-01-07 Impact factor: 32.069
Authors: Monica M Dinardo; Susan M Sereika; Mary Korytkowski; Lynn M Baniak; Valarie A Weinzierl; Amy L Hoenstine; Eileen R Chasens Journal: Diabetes Educ Date: 2019-02-12 Impact factor: 2.140